Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

532 ARTÍCULOS , VIENDO DEL 211 AL 225

Synthesis, characterization, and biological studies of chalcone derivatives containing Schiff bases: Synthetic derivatives for the treatment of epilepsy and Alzheimer's disease

Koçyiğit ÜM, Gezegen H, Taslimi P.

Arch Pharm (Weinheim). 2020 Dec;353(12):e2000202. doi: 10.1002/ardp.202000202. Epub 2020 Aug 20.

Nanoparticles Based Intranasal Delivery of Drug to Treat Alzheimer's Disease: A Recent Update

Pandey M, Choudhury H, Verma RK, Chawla V, Bhattamisra SK, Gorain B, Raja MAG, Amjad MW.

CNS Neurol Disord Drug Targets. 2020;19(9):648-662. doi: 10.2174/1871527319999200819095620.

ATP synthase and Alzheimer's disease: putting a spin on the mitochondrial hypothesis

Ebanks B, Ingram TL, Chakrabarti L.

Aging (Albany NY). 2020 Aug 27;12(16):16647-16662. doi: 10.18632/aging.103867. Epub 2020 Aug 27.

A role for sodium glucose cotransporter 2 inhibitors (SGLT2is) in the treatment of Alzheimer's disease?

Esterline R, Oscarsson J, Burns J.

Int Rev Neurobiol. 2020;155:113-140. doi: 10.1016/bs.irn.2020.03.018. Epub 2020 Aug 11.

Therapeutic potentials of neural stem cells in Alzheimer's disease

Wong RSY, Cheong SK.

Malays J Pathol. 2020 Aug;42(2):157-170.

Unwinding Complexities of Diabetic Alzheimer by Potent Novel Molecules

Gupta S, Nair A, Jhawat V, Mustaq N, Sharma A, Dhanawat M, Khan SA.

Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520937542. doi: 10.1177/1533317520937542.

Review of beneficial effects of resveratrol in neurodegenerative diseases such as Alzheimer's disease

Komorowska J, Wątroba M, Szukiewicz D.

Adv Med Sci. 2020 Sep;65(2):415-423. doi: 10.1016/j.advms.2020.08.002. Epub 2020 Aug 29.

ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease

Lanfranco MF, Ng CA, Rebeck GW.

Int J Mol Sci. 2020 Sep 1;21(17):6336. doi: 10.3390/ijms21176336.

Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer's Disease: A State-of-the-Art (2017-2020)

Binda A, Murano C, Rivolta I.

Int J Nanomedicine. 2020 Aug 14;15:6113-6135. doi: 10.2147/IJN.S231480. eCollection 2020.

Memantine Derivatives as Multitarget Agents in Alzheimer's Disease

Marotta G, Basagni F, Rosini M, Minarini A.

Molecules. 2020 Sep 2;25(17):4005. doi: 10.3390/molecules25174005.

Boosting the autophagy-lysosomal pathway by phytochemicals: A potential therapeutic strategy against Alzheimer's disease

Nourbakhsh F, Read MI, Barreto GE, Sahebkar A.

IUBMB Life. 2020 Nov;72(11):2360-2281. doi: 10.1002/iub.2369. Epub 2020 Sep 7.

Adiponectin: The Potential Regulator and Therapeutic Target of Obesity and Alzheimer's Disease

Kim JY, Barua S, Jeong YJ, Lee JE.

Int J Mol Sci. 2020 Sep 3;21(17):6419. doi: 10.3390/ijms21176419.

Molecular mechanism of zinc neurotoxicity in Alzheimer's disease

Narayanan SE, Rehuman NA, Harilal S, Vincent A, Rajamma RG, Behl T, Uddin MS, Ashraf GM, Mathew B.

Environ Sci Pollut Res Int. 2020 Dec;27(35):43542-43552. doi: 10.1007/s11356-020-10477-w. Epub 2020 Sep 9.

Memantine, Donepezil, or Combination Therapy-What is the best therapy for Alzheimer's Disease? A Network Meta-Analysis

Guo J, Wang Z, Liu R, Huang Y, Zhang N, Zhang R.

Brain Behav. 2020 Nov;10(11):e01831. doi: 10.1002/brb3.1831. Epub 2020 Sep 10.

Effect of statins on amyloidosis in the rodent models of Alzheimer's disease: Evidence from the preclinical meta-analysis

Rahman SO, Hussain S, Alzahrani A, Akhtar M, Najmi AK.

Brain Res. 2020 Dec 15;1749:147115. doi: 10.1016/j.brainres.2020.147115. Epub 2020 Sep 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias